Connection

Co-Authors

This is a "connection" page, showing publications co-authored by ANDREW J BISHOP and DEBRA NANA YEBOA.
Connection Strength

1.513
  1. Definitive single fraction spine stereotactic radiosurgery for metastatic sarcoma: Simultaneous integrated boost is associated with high tumor control and low vertebral fracture risk. Radiother Oncol. 2024 Apr; 193:110119.
    View in: PubMed
    Score: 0.246
  2. Relationship between treatment center case volume and survival for localized Ewing sarcoma: The role of radiotherapy timing. Pediatr Blood Cancer. 2020 11; 67(11):e28685.
    View in: PubMed
    Score: 0.194
  3. National Patterns of Care in the Management of World Health Organization Grade II and III Spinal Ependymomas. World Neurosurg. 2019 Apr; 124:e580-e594.
    View in: PubMed
    Score: 0.173
  4. Timing of Local Therapy Affects Survival in Ewing Sarcoma. Int J Radiat Oncol Biol Phys. 2019 05 01; 104(1):127-136.
    View in: PubMed
    Score: 0.173
  5. Management of chordoma and chondrosarcoma with definitive dose-escalated single-fraction spine stereotactic radiosurgery. J Neurooncol. 2023 Sep; 164(2):377-386.
    View in: PubMed
    Score: 0.060
  6. Safety and efficacy of salvage conventional re-irradiation following stereotactic radiosurgery for spine metastases. Radiat Oncol J. 2023 Mar; 41(1):12-22.
    View in: PubMed
    Score: 0.058
  7. A Prospective Study of Conventionally Fractionated Dose Constraints for Reirradiation of Primary Brain Tumors in Adults. Pract Radiat Oncol. 2023 May-Jun; 13(3):231-238.
    View in: PubMed
    Score: 0.057
  8. Safety and Efficacy of Dose-Escalated Radiation Therapy With a Simultaneous Integrated Boost for the Treatment of Spinal Metastases. Pract Radiat Oncol. 2023 Jan-Feb; 13(1):e7-e13.
    View in: PubMed
    Score: 0.056
  9. Comparison of setup accuracy and efficiency between the Klarity system and BodyFIX system for spine stereotactic body radiation therapy. J Appl Clin Med Phys. 2022 Nov; 23(11):e13804.
    View in: PubMed
    Score: 0.056
  10. Advances in the management of spinal metastases: what the radiologist needs to know. Br J Radiol. 2023 Jan 01; 96(1141):20220267.
    View in: PubMed
    Score: 0.056
  11. Definitive radiotherapy for extracranial oligoprogressive metastatic renal cell carcinoma as a strategy to defer systemic therapy escalation. BJU Int. 2022 05; 129(5):610-620.
    View in: PubMed
    Score: 0.052
  12. Spinal laser interstitial thermal therapy: single-center experience and outcomes in the first 120 cases. J Neurosurg Spine. 2020 Dec 11; 34(3):354-363.
    View in: PubMed
    Score: 0.050
  13. Low risk of radiation myelopathy with relaxed spinal cord dose constraints in de novo, single fraction spine stereotactic radiosurgery. Radiother Oncol. 2020 11; 152:49-55.
    View in: PubMed
    Score: 0.048
  14. Radiation for Glioblastoma in the Era of Coronavirus Disease 2019 (COVID-19): Patient Selection and Hypofractionation to Maximize Benefit and Minimize Risk. Adv Radiat Oncol. 2020 Jul-Aug; 5(4):743-745.
    View in: PubMed
    Score: 0.048
  15. Spine stereotactic radiosurgery for metastases from hepatobiliary malignancies: patient selection using PRISM scoring. J Neurooncol. 2020 Jun; 148(2):327-334.
    View in: PubMed
    Score: 0.047
  16. Spine stereotactic radiosurgery for metastatic thyroid cancer: a single-institution experience. J Neurosurg Spine. 2020 Feb 14; 1-9.
    View in: PubMed
    Score: 0.047
  17. A comparison of spinal laser interstitial thermotherapy with open surgery for metastatic thoracic epidural spinal cord compression. J Neurosurg Spine. 2020 Jan 03; 1-9.
    View in: PubMed
    Score: 0.046
  18. Assembling the brain trust: the multidisciplinary imperative in neuro-oncology. Nat Rev Clin Oncol. 2019 08; 16(8):521-522.
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.